| Yoga Practice for Breast or Ovarian Cancer Patients (NCT02305498) | Memorial Sloan Kettering Cancer Center | 2014-11-24 |
| Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL) (NCT02301364) | Memorial Sloan Kettering Cancer Center | 2014-11-20 |
| Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments (NCT02296450) | Memorial Sloan Kettering Cancer Center | 2014-11-18 |
| Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy? (NCT02286843) | Memorial Sloan Kettering Cancer Center | 2014-11-06 |
| MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer: The IMAGINg and Epidemiology (IMAGINE) Study (NCT02301767) | Memorial Sloan Kettering Cancer Center | 2014-11-01 |
| PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot Study (NCT02307630) | Memorial Sloan Kettering Cancer Center | 2014-11-01 |
| Improving Health of Patients With Colon Cancer Following Surgery: A Trial of SA-ICAN Via Videoconferencing (NCT02301338) | Memorial Sloan Kettering Cancer Center | 2014-11-01 |
| [18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate Cancer (NCT02297386) | Memorial Sloan Kettering Cancer Center | 2014-11-01 |
| Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer (NCT02285192) | Memorial Sloan Kettering Cancer Center | 2014-11-01 |
| Cetuximab + BYL719 + IMRT (Intensity-Modulated Radiation Therapy) in Stage III/IVB Head and Neck Squamous Cell Cancer (HNSCC) (NCT02282371) | Memorial Sloan Kettering Cancer Center | 2014-10-30 |
| Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer (NCT02280356) | Memorial Sloan Kettering Cancer Center | 2014-10-28 |
| Trial for Salvage Re-Irradiation of Metastatic Spine Lesions Using Single-Fraction Stereotactic Radiosurgery (NCT02278744) | Memorial Sloan Kettering Cancer Center | 2014-10-27 |
| Diffusion Weighted Imaging as a Biomarker for Detection of Chemotherapy Induced Cardiotoxicity (NCT02274480) | Memorial Sloan Kettering Cancer Center | 2014-10-22 |
| Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers (NCT02269293) | Memorial Sloan Kettering Cancer Center | 2014-10-13 |
| Non-Randomized Trial Assessing Pain Efficacy With Radium-223 in Symptomatic Metastatic Castration-Resistant Prostate Cancer (NCT02278055) | Memorial Sloan Kettering Cancer Center | 2014-10-08 |
| BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST) (NCT02257541) | Memorial Sloan Kettering Cancer Center | 2014-10-02 |
| Evaluate the Response to 2 Induction Courses (12 Intravesical Instillations) of Bacillus Calmette-Guérin (BCG) for High Risk Superficial Bladder Cancer (NCT02281383) | Memorial Sloan Kettering Cancer Center | 2014-10-01 |
| Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma (NCT02282358) | Memorial Sloan Kettering Cancer Center | 2014-10-01 |
| Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation (NCT02269150) | Memorial Sloan Kettering Cancer Center | 2014-10-01 |
| Safety, Tolerability, and Immunoregulatory Activity of Mogamulizumab (KW-0761) in Subjects With Advanced and/or Metastatic Solid Tumors (NCT02281409) | Memorial Sloan Kettering Cancer Center | 2014-10-01 |
| Assessing Insulin Sensitivity and Diabetes Risk in Childhood Cancer Survivors Treated With Abdominal Irradiation (NCT02248779) | Memorial Sloan Kettering Cancer Center | 2014-09-22 |
| Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells and Evaluation of Globin Gene Transfer in Patients With Sickle Cell Disease (NCT02193191) | Memorial Sloan Kettering Cancer Center | 2014-09-17 |
| Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection (NCT02241187) | Memorial Sloan Kettering Cancer Center | 2014-09-12 |
| Nintedanib in Patients With Advanced Esophagogastric Cancer (NCT02234596) | Memorial Sloan Kettering Cancer Center | 2014-09-04 |
| Exercise and QUality Diet After Leukemia: The EQUAL Study (NCT02244411) | Memorial Sloan Kettering Cancer Center | 2014-09-01 |
| Local Control With Reduced-dose Radiotherapy for High-Risk Neuroblastoma (NCT02245997) | Memorial Sloan Kettering Cancer Center | 2014-09-01 |
| Care For The Cancer Caregiver: A Meaning-Based Workshop To Help Manage Caregiver Burden (NCT02250911) | Memorial Sloan Kettering Cancer Center | 2014-09-01 |
| Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Myelodysplastic Syndromes (NCT02228525) | Memorial Sloan Kettering Cancer Center | 2014-08-27 |
| Effect of Autologous Blood Patch Injection Versus BioSentry Hydrogel Tract Plug in the Reduction of Pneumothorax Risk Following Lung Biopsy Procedures (NCT02224924) | Memorial Sloan Kettering Cancer Center | 2014-08-21 |
| IFACT: Incidental Findings in Advanced Cancer Therapy (NCT02217891) | Memorial Sloan Kettering Cancer Center | 2014-08-01 |
| Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer (NCT02218606) | Memorial Sloan Kettering Cancer Center | 2014-08-01 |
| Whole Lung IMRT in Children and Adults With Synovial Sarcoma and Lung Metastases (NCT02181829) | Memorial Sloan Kettering Cancer Center | 2014-07-01 |
| Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management (NCT02199236) | Memorial Sloan Kettering Cancer Center | 2014-07-01 |
| Detection of Oncogenic Tumor Mutations in the Urine and Blood of Lung and Colorectal Cancer Patients (NCT02186236) | Memorial Sloan Kettering Cancer Center | 2014-07-01 |
| Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer (NCT02178345) | Memorial Sloan Kettering Cancer Center | 2014-06-24 |
| Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk Stratification (NCT02177175) | Memorial Sloan Kettering Cancer Center | 2014-06-24 |
| Clinical Utility of Whole Breast Screening Ultrasound in Patients Undergoing Digital Breast Tomosynthesis (NCT02174406) | Memorial Sloan Kettering Cancer Center | 2014-06-23 |
| Identifying and Measuring Depression in Older Cancer Patients (NCT02174055) | Memorial Sloan Kettering Cancer Center | 2014-06-20 |
| Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast Cancer (NCT02167854) | Memorial Sloan Kettering Cancer Center | 2014-06-16 |
| Sacral Neuromodulation (SNM) With InterStimTM for Bowel Dysfunction Following Surgery for Rectal Cancers With Sphincter Preservation (NCT02163187) | Memorial Sloan Kettering Cancer Center | 2014-06-10 |
| Trial of Ruxolitinib and Erlotinib in Patients With EGFR-mutant Lung Adenocarcinoma With Acquired Resistance to Erlotinib (NCT02155465) | Memorial Sloan Kettering Cancer Center | 2014-06-01 |
| A Randomized Trial to Assess Patient Quality of Life and Function After Alternative Surgeries for Pathologic Fractures of the Femur (NCT02164019) | Memorial Sloan Kettering Cancer Center | 2014-06-01 |
| A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical Cystectomy (NCT02145871) | Memorial Sloan Kettering Cancer Center | 2014-05-21 |
| Enhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI-Refractory Thyroid Cancers With the BRAF Inhibitor Vemurafenib: A Pilot Study (NCT02145143) | Memorial Sloan Kettering Cancer Center | 2014-05-20 |
| Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation (NCT02136797) | Memorial Sloan Kettering Cancer Center | 2014-05-08 |
| Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy (NCT02139150) | Memorial Sloan Kettering Cancer Center | 2014-05-01 |
| Benchmarking Intra-tumor Heterogeneity In Ovarian Cancer: Linking In-vivo Imaging Phenotypes With Histology And Genomics (NCT02144311) | Memorial Sloan Kettering Cancer Center | 2014-05-01 |
| Development of Psychotherapeutic Interventions for Parents Who Lost a Child (NCT02153619) | Memorial Sloan Kettering Cancer Center | 2014-05-01 |
| Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell Carcinoma (NCT02131805) | Memorial Sloan Kettering Cancer Center | 2014-05-01 |
| Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer (NCT02121990) | Memorial Sloan Kettering Cancer Center | 2014-04-21 |
| Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas (NCT02120807) | Memorial Sloan Kettering Cancer Center | 2014-04-15 |
| Cognition in Older Breast Cancer Survivors: Treatment Exposure, APOE and Smoking History (NCT02122107) | Memorial Sloan Kettering Cancer Center | 2014-04-08 |
| Targeted Silica Nanoparticles for Real-Time Image-Guided Intraoperative Mapping of Nodal Metastases (NCT02106598) | Memorial Sloan Kettering Cancer Center | 2014-04-03 |
| Tissue and Functional Assessment of Myocardial Injury in Hodgkin Lymphoma (HL) Survivors (NCT02106611) | Memorial Sloan Kettering Cancer Center | 2014-04-01 |
| Meaning-Centered Counseling for Chinese Patients Who Are Being Treated for Advanced Cancer (NCT02112188) | Memorial Sloan Kettering Cancer Center | 2014-04-01 |
| ARN 509 Plus Everolimus in Men With Progressive Metastatic Castration-Resistant Prostate Cancer After Treatment With Abiraterone Acetate (NCT02106507) | Memorial Sloan Kettering Cancer Center | 2014-04-01 |
| Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (NCT02060253) | Memorial Sloan Kettering Cancer Center | 2014-04-01 |
| Calypso-based Deep Inspiration Breath Hold (DIBH) Radiation Treatments of Lung Cancer (NCT02111681) | Memorial Sloan Kettering Cancer Center | 2014-04-01 |
| Quit IT: Preliminary Testing of a Web-based, 3D Coping Skills Game to Increase Quitting Self-Efficacy for Maintaining Smoking Abstinence Following Hospitalization (NCT02099097) | Memorial Sloan Kettering Cancer Center | 2014-03-24 |
| Study Assessing the Potential for Reduced Rates of Implant Failure Using Multi-Beam Intensity-Modulated Radiation Therapy for Locally Advanced Breast Cancer Patients With Implant Reconstructions (NCT02086578) | Memorial Sloan Kettering Cancer Center | 2014-03-11 |
| Dual mTOR Inhibitor MLN0128 in Advanced Castration-Resistant Prostate Cancer (CRPC) Patients (NCT02091531) | Memorial Sloan Kettering Cancer Center | 2014-03-01 |
| Anti-GD2 3F8 Monoclonal Antibody and GM-CSF for High-Risk Neuroblastoma (NCT02100930) | Memorial Sloan Kettering Cancer Center | 2014-03-01 |
| Kidney Cancer DNA Registry (NCT02087852) | Memorial Sloan Kettering Cancer Center | 2014-03-01 |
| Development and Evaluation of Magnetic Resonance Imaging Acquisition and Analysis Methods (NCT02091518) | Memorial Sloan Kettering Cancer Center | 2014-03-01 |
| Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma (NCT02098538) | Memorial Sloan Kettering Cancer Center | 2014-03-01 |
| The Use of Dual-handset Interpreter Phones in an Inpatient Setting to Improve Communication With Limited English Proficiency Patients at MSKCC (NCT02073903) | Memorial Sloan Kettering Cancer Center | 2014-02-24 |
| Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence (NCT02070575) | Memorial Sloan Kettering Cancer Center | 2014-02-20 |
| CT7, MAGE-A3, and WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation (NCT01995708) | Memorial Sloan Kettering Cancer Center | 2014-01-31 |
| Study of Romiplostim for Chemotherapy Induced Thrombocytopenia (NCT02052882) | Memorial Sloan Kettering Cancer Center | 2014-01-30 |
| 18F-Fluorocholine (18F-FCho) to Distinguish Necrosis From Recurrence in Brain Metastases (NCT02037945) | Memorial Sloan Kettering Cancer Center | 2014-01-01 |
| Germ Cell Tumor and Testicular Tumor DNA Registry (NCT02099734) | Memorial Sloan Kettering Cancer Center | 2014-01-01 |
| A Nutritional Management Algorithm in Older Patients With Locally Advanced Esophageal Cancer (NCT02027948) | Memorial Sloan Kettering Cancer Center | 2013-12-23 |
| Combining Ipilimumab, Degarelix, and Radical Prostatectomy in Men With Newly Diagnosed Metastatic Castration Sensitive Prostate Cancer or Ipilimumab and Degarelix in Men With Biochemically Recurrent Castration Sensitive Prostate Cancer After Radical Prostatectomy (NCT02020070) | Memorial Sloan Kettering Cancer Center | 2013-12-18 |
| Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) Patients (NCT02016872) | Memorial Sloan Kettering Cancer Center | 2013-12-16 |
| Regorafenib in Good Performance Status Patients With Newly Diagnosed Metastatic Colorectal Adenocarcinoma (NCT02023333) | Memorial Sloan Kettering Cancer Center | 2013-12-10 |
| PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer (NCT02023996) | Memorial Sloan Kettering Cancer Center | 2013-12-01 |
| Prognostic Awareness and Patient-Physician Communication in Malignant Glioma (NCT02023346) | Memorial Sloan Kettering Cancer Center | 2013-12-01 |
| Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse (NCT01995578) | Memorial Sloan Kettering Cancer Center | 2013-12-01 |
| Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies (NCT01974765) | Memorial Sloan Kettering Cancer Center | 2013-11-05 |
| A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma (NCT01983410) | Memorial Sloan Kettering Cancer Center | 2013-11-04 |
| MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST) (NCT01991379) | Memorial Sloan Kettering Cancer Center | 2013-11-01 |
| Multiplex Testing for Breast Cancer Susceptibility: A Pilot Study of Subject Preferences for Information and Responses After Testing (NCT01992471) | Memorial Sloan Kettering Cancer Center | 2013-11-01 |
| Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management (NCT02008656) | Memorial Sloan Kettering Cancer Center | 2013-11-01 |
| Assessment of Early Treatment Response by Diffusion and Perfusion MRI in Patients With Brain Metastasis (NCT01974804) | Memorial Sloan Kettering Cancer Center | 2013-10-25 |
| Evaluate Esophageal Reinforcement With ACell MatriStem Surgical Matrix: A Degradable Biologic Scaffold Material (NCT01970306) | Memorial Sloan Kettering Cancer Center | 2013-10-18 |
| Low Dose Daily Erlotinib in Combination With High Dose Twice Weekly Erlotinib in Patients With EGFR-Mutant Lung Cancer (NCT01967095) | Memorial Sloan Kettering Cancer Center | 2013-10-15 |
| Placebo Controlled Clinical Trial of the Postoperative Opioid Sparing Effects of Intraoperative Dexmedetomidine Infusion for Thoracic Surgery (NCT01973452) | Memorial Sloan Kettering Cancer Center | 2013-10-01 |
| Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma (NCT01938729) | Memorial Sloan Kettering Cancer Center | 2013-09-05 |
| A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia (NCT01920737) | Memorial Sloan Kettering Cancer Center | 2013-08-07 |
| Response Adapted Therapy With Bortezomib/Dexamethasone Followed by Addition of Lenalidomide in Non Responders as Initial Treatment for Patients With Multiple Myeloma (NCT01919086) | Memorial Sloan Kettering Cancer Center | 2013-08-06 |
| Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT (NCT01931150) | Memorial Sloan Kettering Cancer Center | 2013-08-01 |
| Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer (NCT01916109) | Memorial Sloan Kettering Cancer Center | 2013-08-01 |
| Fluorestradiol (FES) PET/CT for Imaging Estrogen Receptor Status (NCT01916122) | Memorial Sloan Kettering Cancer Center | 2013-08-01 |
| A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma (NCT01908777) | Memorial Sloan Kettering Cancer Center | 2013-07-16 |
| Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer (NCT01899989) | Memorial Sloan Kettering Cancer Center | 2013-07-05 |
| FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancer (NCT01913639) | Memorial Sloan Kettering Cancer Center | 2013-07-01 |
| BRAF Inhibitor, LGX818, Utilizing a Pulsatile Schedule in Patients With Stage IV or Unresectable Stage III Melanoma Characterized by a BRAFV600 Mutation (NCT01894672) | Memorial Sloan Kettering Cancer Center | 2013-07-01 |
| PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative (NCT01916135) | Memorial Sloan Kettering Cancer Center | 2013-07-01 |
| Person-Centered Oncology Care and Choices (P-COCC): Piloting and Initial Randomized Testing of a Combined Values Narrative Interview and Video Education Advance Care Planning Program in Gastrointestinal Oncology Patients (NCT01912131) | Memorial Sloan Kettering Cancer Center | 2013-07-01 |
| Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer (NCT01882816) | Memorial Sloan Kettering Cancer Center | 2013-06-13 |